Enzalutamide as a Radiosensitizer in Prostate Cancer Cell Lines

被引：0
|
作者：
Barrado, M. [1 ]
Escors, D. [2 ]
Arias, F. [1 ]
Blanco, I. [2 ]
Arteta, V. [2 ]
Visus, I. [1 ]
Campo, M. [1 ]
Flamarique, S. [1 ]
Navarrete, P. A. [1 ]
Martinez, E. [1 ]
机构：
[1] Complejo Hosp Navarra Pamplona, Pamplona, Spain
[2] Fdn Miguel Servet, Pamplona, Spain
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2017年 / 99卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2017.06.1111
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2510
引用
收藏
页码：E212 / E212
页数：1
相关论文
共 50 条
  • [21] Equol as a radiosensitizer and therapeutic agent in prostate cancer
    Jones, Carli B.
    Coulter, Jonathan B.
    Maynard, Janielle P.
    Mummert, Luke A.
    Phillips, Ryan M.
    Tran, Phuoc T.
    Sfanos, Karen S.
    CANCER RESEARCH, 2022, 82 (12)
  • [22] Sulfoquinovosylacylpropanediol is a novel potent radiosensitizer in prostate cancer
    Sawada, Yugo
    Omoto, Kazuya
    Kohei, Naoki
    Sakaguchi, Kengo
    Miura, Masahiko
    Tanabe, Kazunari
    INTERNATIONAL JOURNAL OF UROLOGY, 2015, 22 (06) : 590 - 595
  • [23] Enzalutamide and metastasis risk in prostate cancer
    Gourd, Elizabeth
    LANCET ONCOLOGY, 2018, 19 (08): : E387 - E387
  • [24] Enzalutamide in Prostate Cancer after Chemotherapy
    Berruti, Alfredo
    Generali, Daniele
    Tampellini, Marco
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (25): : 2448 - 2448
  • [25] Enzalutamide prolongs prostate cancer survival
    Mayor, Susan
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2019, 80 (07) : 370 - 370
  • [26] Stem Cell Characteristics in Prostate Cancer Cell Lines
    Pfeiffer, Minja J.
    Schalken, Jack A.
    EUROPEAN UROLOGY, 2010, 57 (02) : 246 - 254
  • [27] Effect of the phytochemical crinumaquine on prostate and prostate cancer cell lines
    Liu, Run-Hui
    Jin, Huizi
    Ke, Xi-Song
    Qu, Yi
    Hellem, Margrete R.
    Rostad, Kari
    Oyan, Anne Margrete
    Kalland, Karl H.
    Zhang, Wei-Dong
    CANCER RESEARCH, 2012, 72
  • [28] Linking prostate cancer cell AR heterogeneity to distinct castration and enzalutamide responses
    Li, Qiuhui
    Deng, Qu
    Chao, Hsueh-Ping
    Liu, Xin
    Lu, Yue
    Lin, Kevin
    Liu, Bigang
    Tang, Gregory W.
    Zhang, Dingxiao
    Tracz, Amanda
    Jeter, Collene
    Rycaj, Kiera
    Calhoun-Davis, Tammy
    Huang, Jiaoti
    Rubin, Mark A.
    Beltran, Himisha
    Shen, Jianjun
    Chatta, Gurkamal
    Puzanov, Igor
    Mohler, James L.
    Wang, Jianmin
    Zhao, Ruizhe
    Kirk, Jason
    Chen, Xin
    Tang, Dean G.
    NATURE COMMUNICATIONS, 2018, 9
  • [29] Linking prostate cancer cell AR heterogeneity to distinct castration and enzalutamide responses
    Qiuhui Li
    Qu Deng
    Hsueh-Ping Chao
    Xin Liu
    Yue Lu
    Kevin Lin
    Bigang Liu
    Gregory W. Tang
    Dingxiao Zhang
    Amanda Tracz
    Collene Jeter
    Kiera Rycaj
    Tammy Calhoun-Davis
    Jiaoti Huang
    Mark A. Rubin
    Himisha Beltran
    Jianjun Shen
    Gurkamal Chatta
    Igor Puzanov
    James L. Mohler
    Jianmin Wang
    Ruizhe Zhao
    Jason Kirk
    Xin Chen
    Dean G. Tang
    Nature Communications, 9
  • [30] Linking prostate cancer cell AR heterogeneity to distinct castration and Enzalutamide responses
    Li, Qiuhui
    Chen, Xin
    Deng, Qu
    Chao, Hsueh-Ping
    Tracz, Amanda
    Kirk, Jason
    Zhao, Ruizhe
    Rycaj, Kiera
    Tang, Dean G.
    CANCER RESEARCH, 2018, 78 (13)
12345